Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 1,000 points on Monday.

Shares of Valneva SE (NASDAQ:VALN) fell sharply in pre-market trading.

Pfizer (NYSE:PFE) and Valneva disclosed topline results from Phase 3 VALOR clinical trial of investigational 6-Valent OspA-based Lyme disease vaccine candidate PF-0730740.

Valneva shares dipped 14% to $8.88 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• LiveWire Group Inc (NASDAQ:LVWR) shares dipped 14.6% to $1.04 in pre-market trading after dipping 10% on Friday.
• Anghami Inc (NASDAQ:ANGH) declined 14.3% to $2.40 in pre-market trading after dipping 12% on Friday.
• Golar LNG Ltd (NASDAQ:GLNG) fell 11% to $46.90 in pre-market trading.
• Kosmos Energy Ltd (NYSE:KOS) fell 10.2% to $2.55 in pre-market trading.
• Swarmer Inc (NASDAQ:SWMR) declined 9.3% to $33.30 in pre-market trading.
• Equinor ASA (NYSE:EQNR) fell 8.2% to $38.21 in pre-market trading.
• CF Industries Holdings, Inc. (NYSE:CF) fell 7.1% to $116.00 in pre-market trading.
• Venture Global Inc (NYSE:VG) fell 7% to $14.70 in pre-market trading. Venture Global and Vitol reported a new LNG purchase agreement.
• SM Energy Co (NYSE:SM) fell 5.1% to $28.50 in pre-market trading.
• PepGen Inc (NASDAQ:PEPG) fell 5.1% to $4.46 in pre-market trading. PepGen recently reported fourth-quarter financial results. The FDA placed a partial hold on the company’s FREEDOM2-DM1 Phase 2 multiple ascending dose, randomized, placebo-controlled clinical trial of PGN-EDODM1 in patients with myotonic dystrophy type 1.

Photo via Shutterstock